Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The Centers for Medicare and Medicaid Services’ annual outpatient hospital pay increase proposal has come with a potential major change to 340B drug payment rates and a continued push toward lower | A substantial 340B reimbursement rate cut, reduced payments for hospitals' outpatient imaging services and other changes raised immediate alarms among hospital groups.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The Centers for Medicare and Medicaid Services’ recent proposal to overhaul Medicare’s reimbursement rates for 340B drugs will be…

Alongside their annual criticisms of the Centers for Medicare and Medicaid Services’ annual pay rate increase for inpatient care,…

The Trump administration proposed major changes to Medicare payment policies that will block third-party vendors from remote…

The Trump administration is proposing sweeping changes to Medicare payment and value-based care programs it says will expand…

The Centers for Medicare and Medicaid Services on Friday locked in a 2.3% increase for base inpatient hospital payments for…

Outpatient drug purchases under the 340B Drug Pricing Program crossed the $100 billion mark across 2025, a roughly 23% increase…